US Stock MarketDetailed Quotes

VKTX Viking Therapeutics

Watchlist
  • 50.100
  • +0.260+0.52%
Close Jul 18 16:00 ET
  • 50.600
  • +0.500+1.00%
Post 17:33 ET
5.52BMarket Cap-54456P/E (TTM)

Viking Therapeutics Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Viking Therapeutics Earnings Date

Currency: USD

Period

Q2 FY2024 Estimates

Jul 24, 2024

Revenue(YoY)

0.00

0.00%
EPS(YoY)

-0.27

-41.65%
Analyst Rating

Strong Buy

Jul 18, 2024

Viking Therapeutics Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 11 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: USD

Actual
Estimate
DatePeriodRevenue/EstimateEarnings Call
--2024/Q3-- / 0.000--
Jul 24, 20242024/Q2-- / 0.000--
Apr 24, 20242024/Q10.000 / 0.000--
Feb 7, 20242023/Q40.000 / 0.000--
Oct 25, 20232023/Q30.000 / 0.000--
DatePeriodRevenue/EstimateEarnings Call
--2024/Q3-- / 0.000--
Jul 24, 20242024/Q2-- / 0.000--
Apr 24, 20242024/Q10.000 / 0.000--
Feb 7, 20242023/Q40.000 / 0.000--
Oct 25, 20232023/Q30.000 / 0.000--

Unlock Free Earnings Estimates

Viking Therapeutics Earnings Reports

  • Viking Therapeutics | 10-Q: Quarterly report

    Apr 25 15:24 ET

  • Viking Therapeutics | 10-K: Annual report

    Feb 7 17:27 ET

  • Viking Therapeutics | 10-Q: Q3 2023 Earnings Report

    Oct 25, 2023 17:05 ET

  • Viking Therapeutics | 10-Q: Q2 2023 Earnings Report

    Jul 26, 2023 16:46 ET

    • Read more

    Analysis

    Analyst Rating

    Updated: Jul 18, 2024

    Strong Buy

    • Buy

      100.00%

    • Hold

      0.00%

    • Sell

      0.00%

    Price Target

    No Data

    Heat List
    US
    Overall
    Symbol
    Latest Price
    %Chg
    Concept Weight Loss Drugs
    Weight Loss Drugs
    Intraday-4.53%